Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

View all Images (12)

Targetoid hemosiderotic hemangioma
Other Resources UpToDate PubMed

Targetoid hemosiderotic hemangioma

Contributors: Kisha Kalra, Keith Morley MD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Targetoid hemosiderotic hemangioma (THH), also known as targetoid hemosiderotic lymphatic malformation (THLM), is a benign lesion characterized clinically by a solitary central, brown-violaceous papule with or without a surrounding thin, pale area and ring of ecchymosis, creating a targetoid appearance. While THH was once thought to be of vascular origin, immunohistochemical data support its lymphatic origin, as THH stains positively for lymphatic markers including D2-40. Additionally, immunohistochemical studies have shown a pattern that is more consistent with a vascular malformation than a neoplasm, as implied by the term "hemangioma."

THH is a rare finding that tends to appear in young or middle-aged individuals. It has a predilection for the trunk and/or extremities. No definitive risk factors exist, although it is speculated that trauma may play a role in the development and flaring of these lesions.

Codes

ICD10CM:
D18.01 – Hemangioma of skin and subcutaneous tissue

SNOMEDCT:
254790003 – Targetoid hemosiderotic hemangioma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:12/25/2021
Last Updated:01/17/2022
Copyright © 2022 VisualDx®. All rights reserved.
Targetoid hemosiderotic hemangioma
A medical illustration showing key findings of Targetoid hemosiderotic hemangioma : Smooth papule, Targetoid configuration, Single skin lesion
Copyright © 2022 VisualDx®. All rights reserved.